Pb2012: a phase 2 multiarm study of magrolimab combinations in patients with relapsed/refractory multiple myeloma

B. Paul,M. Liedtke,D. S. Siegel,J. Khouri, J. Hillenglass,R. Rifkin,M. D. Gandhi,A. Kin,M. Y. Levy,A. Mohrbacher, W. Schmidt,R. Silbermann,F. Cottini,D. W. Sborov, R. Walker,M. Murphy, L. Gu, A. Chen,N. Rajakumaraswamy,S. Z. Usmani

HemaSphere（2022）

Cited 0|Views2
No score
Key words
relapsed/refractory multiple myeloma,multiple myeloma,magrolimab combinations,multiarm study
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined